Published: 2022-06-28

Speech therapy for dysarthric disorders in amyotrophic lateral sclerosis

Ewa Boksa Logo ORCID , Katarzyna Żabińska Logo ORCID

Abstract

The presented paper concerns the diagnostics and therapy of dysarthria in the course of amyotrophic lateral sclerosis (ALS, sclerosis lateralis amyotrophica, SLA, Charcot disease), one of the incurable neurodegenerative diseases. On the example of a 46-year-old patient, the characteristic symptoms of the disease were analyzed in relation to the speech therapy literature. The article was presented in the form of a case study due to the small number of patients with amyotrophic lateral sclerosis. The incidence of sporadic amyotrophic lateral sclerosis (SSLA) is on average 1.9 per 100,000 per year in both Europe and North America. The incidence of SLA is estimated to be about 7 out of 100,000 in the general population. The study used the “Ocena stanu dyzartrii” [Assessment of dysarthria status] by Izabela Gatkowska was supplemented with an interview with
the respondent and available medical documentation, and then a therapy plan was proposed.

Citation rules

Boksa, E., & Żabińska, K. (2022). Speech therapy for dysarthric disorders in amyotrophic lateral sclerosis. Logopedia Silesiana, 11(1), 1–45. https://doi.org/10.31261/LOGOPEDIASILESIANA.2022.11.01.03

Cited by / Share

Vol. 11 No. 1 (2022)
Published: 2022-07-01


ISSN: 2300-5246
eISSN: 2391-4297
Ikona DOI 10.31261/LOGOPEDIASILESIANA

Publisher
Wydawnictwo Uniwersytetu Śląskiego | University of Silesia Press

This website uses cookies for proper operation, in order to use the portal fully you must accept cookies.